Variant report

Variant	nsv819832
Chromosome Location	chr17:46653301-46654188
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:157)
CpG islands
(count:122)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:157 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:46653738-46653938	K562	blood:	n/a	n/a
2	ARID3A	chr17:46654157-46654342	K562	blood:	n/a	n/a
3	BHLHE40	chr17:46654099-46654719	K562	blood:	n/a	n/a
4	CCNT2	chr17:46654035-46654454	K562	blood:	n/a	n/a
5	CEBPB	chr17:46653993-46654359	K562	blood:	n/a	n/a
6	CEBPB	chr17:46654173-46654317	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr17:46654009-46654383	K562	blood:	n/a	n/a
8	CEBPB	chr17:46654019-46654438	MCF-7	breast:	n/a	n/a
9	CEBPB	chr17:46654025-46654454	MCF-7	breast:	n/a	n/a
10	CEBPB	chr17:46654085-46654314	K562	blood:	n/a	n/a
11	CEBPB	chr17:46653997-46654358	IMR90	lung:	n/a	n/a
12	CEBPD	chr17:46653984-46654454	K562	blood:	n/a	n/a
13	CHD1	chr17:46654042-46655886	IMR90	lung:	n/a	chr17:46655015-46655022
14	CHD1	chr17:46641810-46654030	IMR90	lung:	n/a	n/a
15	CTBP2	chr17:46654124-46655257	H1-hESC	embryonic stem cell:	n/a	n/a
16	E2F6	chr17:46654021-46654384	K562	blood:	n/a	n/a
17	EGR1	chr17:46654152-46654298	GM12878	blood:	n/a	n/a
18	EGR1	chr17:46654017-46654976	HCT-116	colon:	n/a	chr17:46654693-46654706 chr17:46654692-46654707
19	EGR1	chr17:46654017-46654613	MCF-7	breast:	n/a	n/a
20	EGR1	chr17:46653931-46654562	HCT-116	colon:	n/a	n/a
21	EGR1	chr17:46653986-46656259	K562	blood:	n/a	chr17:46654693-46654706 chr17:46655140-46655155 chr17:46655913-46655928 chr17:46654692-46654707 chr17:46655909-46655924 chr17:46655319-46655333
22	EGR1	chr17:46654034-46654540	MCF-7	breast:	n/a	n/a
23	EGR1	chr17:46654016-46654395	GM12878	blood:	n/a	n/a
24	EGR1	chr17:46654013-46654426	K562	blood:	n/a	n/a
25	EGR1	chr17:46654020-46654594	ECC-1	luminal epithelium:	n/a	n/a
26	EGR1	chr17:46654021-46654496	ECC-1	luminal epithelium:	n/a	n/a
27	EP300	chr17:46654111-46654435	K562	blood:	n/a	chr17:46654401-46654415
28	EP300	chr17:46653791-46655598	ECC-1	luminal epithelium:	n/a	chr17:46654401-46654415
29	EP300	chr17:46653981-46654595	ECC-1	luminal epithelium:	n/a	chr17:46654401-46654415
30	GATA1	chr17:46654131-46654468	PBDE	blood:	n/a	n/a
31	GATA2	chr17:46654020-46654455	K562	blood:	n/a	n/a
32	GATA3	chr17:46654057-46654402	T-47D	breast:	n/a	n/a
33	GATA3	chr17:46653891-46654606	MCF-7	breast:	n/a	n/a
34	GATA3	chr17:46654022-46654445	T-47D	breast:	n/a	n/a
35	GATA3	chr17:46653888-46654602	MCF-7	breast:	n/a	n/a
36	GATA3	chr17:46654119-46654435	MCF-7	breast:	n/a	n/a
37	HA-E2F1	chr17:46654078-46654717	MCF-7	breast:	n/a	chr17:46654478-46654490
38	HCFC1	chr17:46654129-46654349	K562	blood:	n/a	n/a
39	HDAC2	chr17:46654084-46654337	K562	blood:	n/a	n/a
40	HDAC2	chr17:46653981-46654523	MCF-7	breast:	n/a	chr17:46654400-46654414
41	HDAC2	chr17:46654026-46654459	MCF-7	breast:	n/a	chr17:46654400-46654414
42	HEY1	chr17:46654040-46655408	K562	blood:	n/a	n/a
43	HEY1	chr17:46653275-46653809	K562	blood:	n/a	n/a
44	HEY1	chr17:46654061-46654469	K562	blood:	n/a	n/a
45	HMGN3	chr17:46654077-46654336	K562	blood:	n/a	n/a
46	IRF1	chr17:46652558-46653496	K562	blood:	n/a	chr17:46653145-46653166
47	JUND	chr17:46654137-46654341	K562	blood:	n/a	n/a
48	MAFK	chr17:46653643-46653660	K562	blood:	n/a	n/a
49	MAX	chr17:46654060-46654449	K562	blood:	n/a	n/a
50	MAX	chr17:46653920-46654638	K562	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:46653711-46653761	NB4	blood:	n/a
2	chr17:46653711-46653761	HNPCEpiC	eye:	n/a
3	chr17:46653615-46653665	MCF-7	breast:	n/a
4	chr17:46653711-46653761	Hela-S3	cervix:	n/a
5	chr17:46653711-46653761	K562	blood:	n/a
6	chr17:46653711-46653761	NHDF-neo	bronchial:	n/a
7	chr17:46653711-46653761	HIPEpiC	eye:	n/a
8	chr17:46653711-46653761	HUVEC	blood vessel:	n/a
9	chr17:46653615-46653665	HPAEpiC	pulmonary alveolar:	n/a
10	chr17:46653615-46653665	PrEC	prostate:	n/a
11	chr17:46653615-46653665	AG09309	skin:	n/a
12	chr17:46653615-46653665	HMEC	breast:	n/a
13	chr17:46653615-46653665	T-47D	breast:	n/a
14	chr17:46653615-46653665	HAEpiC	amniotic membrane:	n/a
15	chr17:46653615-46653665	HCF	heart:	n/a
16	chr17:46653615-46653665	HepG2	liver:	n/a
17	chr17:46653711-46653761	PFSK-1	brain:	n/a
18	chr17:46653615-46653665	CMK	blood:	n/a
19	chr17:46653615-46653665	HUVEC	blood vessel:	n/a
20	chr17:46653615-46653665	BJ	skin:	n/a
21	chr17:46653711-46653761	BJ	skin:	n/a
22	chr17:46653711-46653761	HPAEpiC	pulmonary alveolar:	n/a
23	chr17:46653711-46653761	HCM	heart:	n/a
24	chr17:46653615-46653665	H1-hESC	embryonic stem cell:	embryo
25	chr17:46653615-46653665	NHDF-neo	bronchial:	n/a
26	chr17:46653711-46653761	BE2_C	brain:	n/a
27	chr17:46653711-46653761	H1-hESC	embryonic stem cell:	embryo
28	chr17:46653711-46653761	Hepatocyte	liver:	n/a
29	chr17:46653615-46653665	GM19239	blood:	n/a
30	chr17:46653615-46653665	NT2-D1	testis:	n/a
31	chr17:46653711-46653761	HAEpiC	amniotic membrane:	n/a
32	chr17:46653711-46653761	LNCaP	prostate:	n/a
33	chr17:46653615-46653665	SK-N-MC	brain:	n/a
34	chr17:46653711-46653761	GM12891	blood:	n/a
35	chr17:46653711-46653761	SK-N-SH	brain:	n/a
36	chr17:46653711-46653761	AG04450	lung:	fetal
37	chr17:46653711-46653761	HL-60	blood:	n/a
38	chr17:46653711-46653761	CMK	blood:	n/a
39	chr17:46653615-46653665	NH-A	brain:	n/a
40	chr17:46653711-46653761	HRE	kidney:	n/a
41	chr17:46653711-46653761	PANC-1	pancreas:	n/a
42	chr17:46653711-46653761	AG04449	skin:	fetal
43	chr17:46653615-46653665	HCM	heart:	n/a
44	chr17:46653615-46653665	AG09319	gingival:	n/a
45	chr17:46653615-46653665	MCF10A-Er-Src	breast:	n/a
46	chr17:46653711-46653761	AG10803	skin:	n/a
47	chr17:46653711-46653761	U87	brain:	n/a
48	chr17:46653711-46653761	Caco-2	colon:	n/a
49	chr17:46653615-46653665	AG10803	skin:	n/a
50	chr17:46653615-46653665	HIPEpiC	eye:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:46582924..46585539-chr17:46653556..46656243,2	MCF-7	breast:
2	chr17:46652243..46654179-chr17:46657727..46659805,2	MCF-7	breast:

No data

Variant related genes	Relation type
HOXB3	TF binding region
HOXB3	CpG island
ENSG00000257178	chromatin interactions

Extended variants
information (count: 40 )
Associated
traits (count: 116 )

Variant overlapped rSNPs/rCNVs (count:40 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566987154	chr17:46653324-46653325	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs6504397	chr17:46653332-46653333	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs555877435	chr17:46653334-46653335	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs574612183	chr17:46653352-46653353	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs536846720	chr17:46653375-46653376	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs191207508	chr17:46653378-46653379	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs554013777	chr17:46653381-46653382	Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs577020144	chr17:46653472-46653473	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs545407839	chr17:46653536-46653537	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs552519968	chr17:46653546-46653547	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs114420588	chr17:46653602-46653603	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs541556468	chr17:46653617-46653618	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs573616303	chr17:46653643-46653644	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs376184540	chr17:46653647-46653648	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs561618464	chr17:46653649-46653650	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs531181271	chr17:46653695-46653696	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs544433055	chr17:46653715-46653716	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs146689001	chr17:46653784-46653785	Bivalent Enhancer Genic enhancers Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Weak transcription Strong transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs375701346	chr17:46653823-46653824	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs3833172	chr17:46653871-46653872	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs183958025	chr17:46653872-46653873	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs397753496	chr17:46653877-46653878	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs550974918	chr17:46653894-46653895	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs533633764	chr17:46653900-46653901	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs375711835	chr17:46653929-46653930	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs369355466	chr17:46653953-46653954	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs547038749	chr17:46653962-46653963	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs2740755	chr17:46653999-46654000	Bivalent Enhancer Genic enhancers Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs529290290	chr17:46654041-46654042	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs549541586	chr17:46654049-46654050	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs569250918	chr17:46654050-46654051	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs537257453	chr17:46654081-46654082	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs376222523	chr17:46654086-46654087	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs202211147	chr17:46654093-46654094	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs570743872	chr17:46654098-46654099	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs149049923	chr17:46654112-46654113	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs200388738	chr17:46654141-46654142	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs143090260	chr17:46654157-46654158	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs552830566	chr17:46654159-46654160	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs368788191	chr17:46654164-46654165	Bivalent Enhancer Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Active TSS Weak transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:116)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Bladder cancer	21909424	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	16397240	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
Autism	22817714	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Frontotemporal lobar degeneration	19640594	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Breast cancer	21509527	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:157 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:46635000-46654600	Weak transcription	Hela-S3	cervix
2	chr17:46644600-46654200	Weak transcription	Spleen	Spleen
3	chr17:46646400-46654800	Transcr. at gene 5' and 3'	Fetal Stomach	stomach
4	chr17:46647400-46653600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
5	chr17:46648800-46654200	Weak transcription	Primary T cells from cord blood	blood
6	chr17:46648800-46654800	Weak transcription	Gastric	stomach
7	chr17:46649600-46653600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr17:46650400-46653400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
9	chr17:46650600-46653800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
10	chr17:46650600-46654000	Flanking Active TSS	HUVEC	blood vessel
11	chr17:46650600-46654200	Weak transcription	Muscle Satellite Cultured Cells	--
12	chr17:46650600-46655200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
13	chr17:46650800-46653400	Active TSS	Rectal Mucosa Donor 29	rectum
14	chr17:46651000-46653400	Weak transcription	Esophagus	oesophagus
15	chr17:46651000-46653400	Weak transcription	HMEC	breast
16	chr17:46651600-46653400	Enhancers	Rectal Mucosa Donor 31	rectum
17	chr17:46651600-46653800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
18	chr17:46652000-46653600	Transcr. at gene 5' and 3'	NHDF-Ad	bronchial
19	chr17:46652000-46654000	Flanking Active TSS	Stomach Smooth Muscle	stomach
20	chr17:46652400-46653600	Transcr. at gene 5' and 3'	K562	blood
21	chr17:46652400-46654000	Enhancers	HSMMtube	muscle
22	chr17:46652600-46653400	Bivalent Enhancer	Fetal Intestine Large	intestine
23	chr17:46652600-46654000	Genic enhancers	Primary hematopoietic stem cells short term culture	blood
24	chr17:46652600-46654000	Weak transcription	Aorta	Aorta
25	chr17:46652800-46653400	Enhancers	Primary hematopoietic stem cells	blood
26	chr17:46652800-46653400	Enhancers	HSMM	muscle
27	chr17:46652800-46653600	Transcr. at gene 5' and 3'	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr17:46652800-46653600	Enhancers	Small Intestine	intestine
29	chr17:46652800-46653800	Transcr. at gene 5' and 3'	NHLF	lung
30	chr17:46652800-46654200	Enhancers	A549	lung
31	chr17:46652800-46656000	Bivalent/Poised TSS	NH-A	brain
32	chr17:46653000-46653600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr17:46653000-46653800	Strong transcription	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr17:46653000-46653800	Flanking Active TSS	Adipose Nuclei	Adipose
35	chr17:46653000-46653800	Transcr. at gene 5' and 3'	Fetal Kidney	kidney
36	chr17:46653000-46655000	Enhancers	Primary B cells from cord blood	blood
37	chr17:46653000-46655200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr17:46653000-46657200	Transcr. at gene 5' and 3'	IMR90 fetal lung fibroblasts Cell Line	lung
39	chr17:46653200-46653400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr17:46653200-46653400	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
41	chr17:46653200-46653600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
42	chr17:46653200-46653600	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
43	chr17:46653200-46653600	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
44	chr17:46653200-46653600	Bivalent Enhancer	Stomach Mucosa	stomach
45	chr17:46653200-46653600	Flanking Active TSS	GM12878-XiMat	blood
46	chr17:46653200-46653800	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
47	chr17:46653200-46653800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr17:46653200-46653800	Flanking Active TSS	Colonic Mucosa	Colon
49	chr17:46653200-46653800	Flanking Active TSS	Colon Smooth Muscle	Colon
50	chr17:46653200-46653800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links